Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05455424
Title Niraparib Efficacy in Patient With Unresectable Mesothelioma (NERO)
Acronym NERO
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Hospital Southampton NHS Foundation Trust
Age Groups: senior | adult
Covered Countries GBR

No variant requirements are available.